HMB

ID: hmb

Aliases: beta-hydroxy beta-methylbutyrate

Type: compound

Route/form: oral

Status: supplement

Evidence level: human RCT

Best data tier: human controlled/review

Support scope: human, review/regulatory

Source types: human_rct, meta_analysis, review, systematic_review

Linked sources: 7

Broad outcomes: Muscle growth / performance / recovery, mTORC / autophagy / nutrient signaling

Reading note: These are curation notes anchored to linked sources, not a clinical recommendation or protocol.

Targets / mechanism

• leucine metabolite
• muscle protein turnover

Optimization domains

• muscle
• exercise
• catabolism
• mTORC1
• leucine signaling

Research basis

• HMB has a coherent leucine-metabolite mechanism: reduced proteolysis/ubiquitin-pathway activity, mTOR/protein-synthesis signaling, sarcolemma integrity, and muscle-damage/recovery hypotheses.
• Human evidence is strongest as a modest adjunct in older, sarcopenic, clinical, immobilized, or catabolic contexts rather than dramatic hypertrophy in trained young users.
• Young-subject and training meta-analyses provide an important reality check: any effect depends heavily on training status, protein intake, age, and baseline catabolic stress.

Limits, risks, and missing evidence

• Effect sizes in trained healthy users may be modest or absent.
• It is not a substitute for training, adequate protein, energy balance, or pharmacologic anabolic pathways.
• Catabolic/frailty evidence should not be generalized into strong bodybuilding claims.

Risk flags

• standardization uncertainty

Linked papers, labels, and reviews

1. Effects of HMB supplementation during resistance training on strength and body composition
   meta_analysis / pubmed_hmb_training_meta_2009
   Found trivial effects in trained lifters and small effects in untrained men.
2. HMB does not improve resistance-exercise changes in young subjects
   meta_analysis / pubmed_hmb_young_meta_2020
   Systematic review and meta-analysis in young subjects.
3. Effect of beta-hydroxy-beta-methylbutyrate supplementation on muscle loss in older adults
   meta_analysis / pubmed_hmb_older_adults_meta_2015
   Older-adult muscle-loss meta-analysis; helps distinguish frailty/catabolic contexts from trained-young-lifter expectations.
4. Beta-hydroxy-beta-methylbutyrate and its impact on skeletal muscle mass and physical function in clinical practice
   systematic_review / pubmed_hmb_clinical_meta_2019
   Clinical-practice systematic review/meta-analysis for HMB, emphasizing context-specificity of muscle and function outcomes.
5. Mechanism of Action and the Effect of Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation on Different Types of Physical Performance - A Systematic Review
   systematic_review / pubmed_hmb_performance_mechanism_review_2019
   Systematic review discussing HMB mechanisms including proteolysis inhibition, mTOR/protein synthesis, sarcolemma integrity, apoptosis, and exercise-performance contexts.
6. Effects of Beta-Hydroxy-Beta-Methylbutyrate Supplementation on Older Adults with Sarcopenia: A Randomized, Double-Blind, Placebo-Controlled Study
   human_rct / pubmed_hmb_sarcopenia_rct_2023
   Randomized double-blind placebo-controlled study in older adults with sarcopenia; useful for frailty/catabolic-context HMB claims.
7. Beta-hydroxy-beta-methylbutyrate supplementation and skeletal muscle in healthy and muscle-wasting conditions
   review / pubmed_hmb_muscle_review_2017
   Review of HMB effects on skeletal muscle in healthy, exercise, and muscle-wasting contexts; useful for differentiating trained-athlete claims from catabolic settings.